サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1706790

犬のアトピー性皮膚炎市場：世界の産業分析、規模、シェア、成長、動向、2025-2035年予測

Canine Atopic Dermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 242 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
犬のアトピー性皮膚炎市場：世界の産業分析、規模、シェア、成長、動向、2025-2035年予測
出版日: 2025年02月26日
発行: Transparency Market Research
ページ情報: 英文 242 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

犬のアトピー性皮膚炎市場- 調査範囲

TMRの調査レポート「世界の犬のアトピー性皮膚炎市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の犬のアトピー性皮膚炎市場の収益と予測を提供します。また、2025年から2035年までの世界の犬のアトピー性皮膚炎市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、犬のアトピー性皮膚炎市場を推察しました。

市場スナップショット
2024年の市場規模 2億3,140万米ドル
2035年の市場規模 4億3,100万米ドル
CAGR 5.8%

当レポートでは、世界の犬のアトピー性皮膚炎市場の競合情勢について調査しています。世界の犬のアトピー性皮膚炎市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の犬のアトピー性皮膚炎市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の犬のアトピー性皮膚炎市場の市場分析と予測, 2020-2035年

第5章 主要洞察

  • 主要国のヘルスケア支出データ
  • ブランドと価格分析
  • 最近の進歩
  • ポーターのファイブフォース分析
  • 主要地域/国における規制状況
  • 主要地域/国における新規市場参入企業向けの市場開拓戦略
  • サプライチェーン分析
  • バリューチェーン分析
  • PESTEL分析
  • 主要な潜在顧客

第6章 世界の市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：製品タイプ別, 2020-2035年
    • グルココルチコイド
    • 免疫抑制剤
    • モノクローナル抗体
    • カルシニューリン阻害剤
    • ヤヌスキナーゼ（JAK）阻害剤
    • その他
  • 製品タイプ別の市場の魅力

第7章 世界の市場分析と予測：投与経路別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：投与経路別, 2020-2035年
    • トピック
    • 経口
    • 注射剤
  • 投与経路別の市場の魅力

第8章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：流通チャネル別, 2020-2035年
    • 動物病院と診療所
    • 動物用薬局・ドラッグストア
    • eコマース
    • その他
  • 流通チャネル別市場の魅力

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • アルゼンチン
  • チリ
  • ペルー
  • コロンビア
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • Zoetis
    • Merck & Co., Inc.
    • Elanco or its affiliates.
    • Boehringer Ingelheim International GmbH
    • Virbac Corporation
    • Vetoquinol
    • TORAY INDUSTRIES, INC.
    • Biocelix
    • Dechra Pharmaceuticals PLC
    • Bioiberica S.A.U
    • Ceva
    • Bimeda Corporate
    • Other prominent players
図表

List of Tables

  • Table 01: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 02: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 03: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Region, 2020-2035
  • Table 05: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 06: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 07: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 08: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 10: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 11: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 12: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 14: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 15: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 16: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 18: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 19: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 20: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 22: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 23: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 24: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Canine Atopic Dermatitis Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 02: Global Canine Atopic Dermatitis Market Attractiveness Analysis, by Product Type, 2025-2035
  • Figure 03: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Glucocorticoids, 2020-2035
  • Figure 04: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Immunosuppressants, 2020-2035
  • Figure 05: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Monoclonal Antibodies, 2020-2035
  • Figure 06: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Calcineurin Inhibitors, 2020-2036
  • Figure 07: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Janus kinase (JAK) Inhibitor, 2020-2035
  • Figure 08: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 09: Global Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 10: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 11: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Topical, 2020-2035
  • Figure 12: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 13: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Injectable, 2020-2035
  • Figure 14: Global Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 15: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 16: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Veterinary Hospitals and Clinics, 2020-2035
  • Figure 17: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Veterinary Pharmacies & Drug Stores, 2020-2035
  • Figure 18: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by E-commerce, 2020-2035
  • Figure 19: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 20: Global Canine Atopic Dermatitis Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 22: North America - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 23: North America - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 25: North America Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 26: North America Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 27: North America Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 28: North America Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 29: North America - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 30: North America - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 31: Europe - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 32: Europe - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 33: Europe - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 34: Europe Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 35: Europe Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 36: Europe Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 37: Europe Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 38: Europe - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 39: Europe - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 40: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 41: Asia Pacific - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 42: Asia Pacific - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 43: Asia Pacific Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 44: Asia Pacific Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 45: Asia Pacific Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 46: Asia Pacific Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 47: Asia Pacific - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 48: Asia Pacific - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 49: Latin America - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 50: Latin America - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 51: Latin America - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 52: Latin America Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 53: Latin America Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 54: Latin America Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 55: Latin America Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 56: Latin America - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 57: Latin America - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 58: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Middle East & Africa - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 60: Middle East & Africa - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 61: Middle East & Africa Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 62: Middle East & Africa Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 63: Middle East & Africa Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 64: Middle East & Africa Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 65: Middle East & Africa - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Middle East & Africa - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
目次
Product Code: TMRGL86479

Canine Atopic Dermatitis Market - Scope of Report

TMR's report on the global canine atopic dermatitis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global canine atopic dermatitis market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global canine atopic dermatitis market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the canine atopic dermatitis market.

Market Snapshot
Market Value in 2024US$ 231.4 Mn
Market Value in 2035US$ 431 Mn
CAGR5.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global canine atopic dermatitis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global canine atopic dermatitis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global canine atopic dermatitis market.

The report delves into the competitive landscape of the global canine atopic dermatitis market. Key players operating in the global canine atopic dermatitis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global canine atopic dermatitis market profiled in this report.

Key Questions Answered in Global canine atopic dermatitis Market Report:

  • What is the sales/revenue generated by canine atopic dermatitis across all regions during the forecast period?
  • What are the opportunities in the global canine atopic dermatitis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Canine Atopic Dermatitis Market - Research Objectives and Research Approach

The comprehensive report on the global canine atopic dermatitis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global canine atopic dermatitis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global canine atopic dermatitis market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Canine Atopic Dermatitis Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Canine Atopic Dermatitis Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure Data across Key Countries
  • 5.2. Brand and Pricing Analysis
  • 5.3. Recent Advancements in Canine Atopic Dermatitis
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. Regulatory Landscape across Key Regions / Countries
  • 5.6. Go-to-Market Strategy for New Market Entrants across Key Regions / Countries
  • 5.7. Supply Chain Analysis
  • 5.8. Value Chain Analysis
  • 5.9. PESTLE Analysis
  • 5.10. Key Potential Customers

6. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2035
    • 6.3.1. Glucocorticoids
    • 6.3.2. Immunosuppressants
    • 6.3.3. Monoclonal Antibodies
    • 6.3.4. Calcineurin Inhibitors
    • 6.3.5. Janus kinase (JAK) Inhibitor
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2035
    • 7.3.1. Topical
    • 7.3.2. Oral
    • 7.3.3. Injectable
  • 7.4. Market Attractiveness By Route of Administration

8. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Veterinary Hospitals and Clinics
    • 8.3.2. Veterinary Pharmacies & Drug Stores
    • 8.3.3. E-commerce
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Canine Atopic Dermatitis Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020-2035
    • 10.2.1. Glucocorticoids
    • 10.2.2. Immunosuppressants
    • 10.2.3. Monoclonal Antibodies
    • 10.2.4. Calcineurin Inhibitors
    • 10.2.5. Janus kinase (JAK) Inhibitor
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Route of Administration, 2020-2035
    • 10.3.1. Topical
    • 10.3.2. Oral
    • 10.3.3. Injectable
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Veterinary Hospitals and Clinics
    • 10.4.2. Veterinary Pharmacies & Drug Stores
    • 10.4.3. E-commerce
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Canine Atopic Dermatitis Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2035
    • 11.2.1. Glucocorticoids
    • 11.2.2. Immunosuppressants
    • 11.2.3. Monoclonal Antibodies
    • 11.2.4. Calcineurin Inhibitors
    • 11.2.5. Janus kinase (JAK) Inhibitor
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Route of Administration, 2020-2035
    • 11.3.1. Topical
    • 11.3.2. Oral
    • 11.3.3. Injectable
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Veterinary Hospitals and Clinics
    • 11.4.2. Veterinary Pharmacies & Drug Stores
    • 11.4.3. E-commerce
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country

12. Asia Pacific Canine Atopic Dermatitis Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2035
    • 12.2.1. Glucocorticoids
    • 12.2.2. Immunosuppressants
    • 12.2.3. Monoclonal Antibodies
    • 12.2.4. Calcineurin Inhibitors
    • 12.2.5. Janus kinase (JAK) Inhibitor
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020-2035
    • 12.3.1. Topical
    • 12.3.2. Oral
    • 12.3.3. Injectable
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Veterinary Hospitals and Clinics
    • 12.4.2. Veterinary Pharmacies & Drug Stores
    • 12.4.3. E-commerce
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country

13. Latin America Canine Atopic Dermatitis Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2035
    • 13.2.1. Glucocorticoids
    • 13.2.2. Immunosuppressants
    • 13.2.3. Monoclonal Antibodies
    • 13.2.4. Calcineurin Inhibitors
    • 13.2.5. Janus kinase (JAK) Inhibitor
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020-2035
    • 13.3.1. Topical
    • 13.3.2. Oral
    • 13.3.3. Injectable
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Veterinary Hospitals and Clinics
    • 13.4.2. Veterinary Pharmacies & Drug Stores
    • 13.4.3. E-commerce
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Chile
    • 13.5.5. Peru
    • 13.5.6. Colombia
    • 13.5.7. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country

14. Middle East & Africa Canine Atopic Dermatitis Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2035
    • 14.2.1. Glucocorticoids
    • 14.2.2. Immunosuppressants
    • 14.2.3. Monoclonal Antibodies
    • 14.2.4. Calcineurin Inhibitors
    • 14.2.5. Janus kinase (JAK) Inhibitor
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020-2035
    • 14.3.1. Topical
    • 14.3.2. Oral
    • 14.3.3. Injectable
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Veterinary Hospitals and Clinics
    • 14.4.2. Veterinary Pharmacies & Drug Stores
    • 14.4.3. E-commerce
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country

15. Competitive Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Zoetis
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Merck & Co., Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Elanco or its affiliates.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Boehringer Ingelheim International GmbH
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Virbac Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Vetoquinol
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. TORAY INDUSTRIES, INC.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Biocelix
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Dechra Pharmaceuticals PLC
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Bioiberica S.A.U
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Ceva
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Bimeda Corporate
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Other prominent players
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments